SBCM
Schwerin Boyle Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,511
| Closed | -$275K | – | 52 |
|
|
2025
Q1 | $275K | Hold |
4,511
| – | – | 0.03% | 51 |
|
|
2024
Q4 | $255K | Hold |
4,511
| – | – | 0.03% | 52 |
|
|
2024
Q3 | $233K | Sell |
4,511
-950
| -17% | -$49.2K | 0.02% | 51 |
|
|
2024
Q2 | $227K | Hold |
5,461
| – | – | 0.02% | 51 |
|
|
2024
Q1 | $296K | Hold |
5,461
| – | – | 0.03% | 50 |
|
|
2023
Q4 | $280K | Hold |
5,461
| – | – | 0.03% | 51 |
|
|
2023
Q3 | $317K | Sell |
5,461
-268
| -5% | -$15.6K | 0.04% | 50 |
|
|
2023
Q2 | $366K | Sell |
5,729
-3,550
| -38% | -$227K | 0.03% | 46 |
|
|
2023
Q1 | $643K | Buy |
9,279
+804
| +9% | +$55.7K | 0.07% | 42 |
|
|
2022
Q4 | $610K | Hold |
8,475
| – | – | 0.06% | 43 |
|
|
2022
Q3 | $602K | Hold |
8,475
| – | – | 0.07% | 44 |
|
|
2022
Q2 | $653K | Hold |
8,475
| – | – | 0.07% | 44 |
|
|
2022
Q1 | $619K | Hold |
8,475
| – | – | 0.05% | 44 |
|
|
2021
Q4 | $528K | Sell |
8,475
-200
| -2% | -$12.5K | 0.04% | 45 |
|
|
2021
Q3 | $513K | Hold |
8,675
| – | – | 0.04% | 46 |
|
|
2021
Q2 | $580K | Buy |
8,675
+3,775
| +77% | +$252K | 0.05% | 44 |
|
|
2021
Q1 | $309K | Hold |
4,900
| – | – | 0.03% | 47 |
|
|
2020
Q4 | $304K | Buy |
+4,900
| New | +$304K | 0.03% | 49 |
|